Investing in the biotechnology sector is an exercise in patience and not for the faint of heart because the timelines are long, the risk is high and the reward is far from guaranteed.
But a rise in global IPOs, an increase in invested capital and some noteworthy success stories have made this sector attractive and ripe for investment in the past couple of years – even in Canada, where choked-off credit continues to be a challenge in the sector.
Click here for the article.